Vertex Pharmaceuticals Incorporated (VRTX) earnings on August 3, 2026

What the stock did

High
+3.6%
Low
-1.7%
Close
+1.7%

Vertex Pharmaceuticals shares rose 1.71% after the company raised its sales forecast for next year above expectations. The stock hit an intraday high of +3.78% as analysts increased their price targets.

How the outlook turned out

Outlook
Pessimistic · Partial

How each outlook is classified

Written and reviewed by Volatly, the company that organizes the context around corporate events and leaves its archive open to review afterwards.

Who is behind Volatly How each outlook is measured

Notice. This is an archive of already closed events, not financial advice. There is no personalised recommendation here: nobody has asked about your situation or your goals. Volatly organizes the context and publishes its archive with the hits and the misses; the decision and the risk belong to whoever invests.